Inter-observer variation in gross tumour volume delineation of oesophageal cancer on MR, CT and PET/CT

1. World Health Organization International Agency for Research on Cancer (IARC). GLOBOCAN 2020: Estimated cancer incidence, mortality and prevalence worldwide in 2020. [internet]. [cited 2024 Jan 20]. Available at: http://globocan.iarc.fr/ World Health Organization International Agency for Research on Cancer (IARC). GLOBOCAN 2020 Estimated cancer incidence, mortality and prevalence worldwide in 2020 [internet]. [cited 2024 Jan 20]. Available at: http://globocan.iarc.fr/ Search in Google Scholar

2. Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 2020; 13: 1010–21. doi: 10.1007/s12328-020-01237-x UhlenhoppDJ ThenEO SunkaraT GaduputiV Epidemiology of esophageal cancer: update in global trends, etiology and risk factors Clin J Gastroenterol 2020 13 1010 21 10.1007/s12328-020-01237-x Open DOISearch in Google Scholar

3. Stahl M, Mariette C, Haustermans K, Cervantes A, Arnold D. ESMO Guidelines Working Group. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): vi51–6. doi: 10.1093/annonc/mdt342 StahlM MarietteC HaustermansK CervantesA ArnoldD ESMO Guidelines Working Group. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2013 24 Suppl 6 vi51 6 10.1093/annonc/mdt342 Open DOISearch in Google Scholar

4. Eyck BM, Van Lanschot JJB, Hulshof MCCM, van der Wilk BJ, Shapiro J, van Hagen P, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS Trial. J Clin Oncol 2021; 39: 1995–2004. doi: 10.1200/JCO.20.03614 EyckBM Van LanschotJJB HulshofMCCM van der WilkBJ ShapiroJ van HagenP Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS Trial J Clin Oncol 2021 39 1995 2004 10.1200/JCO.20.03614 Open DOISearch in Google Scholar

5. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074–84. doi: 10.1056/NEJMoa1112088 van HagenP HulshofMC van LanschotJJ SteyerbergEW van Berge HenegouwenMI WijnhovenBP Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 2012 366 2074 84 10.1056/NEJMoa1112088 Open DOISearch in Google Scholar

6. Chan KKW, Saluja R, Santos KD, Lien K, Shah K, Cramarossa G, et al. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: a network meta-analysis. Int J Cancer 2018; 143: 430–37. doi: 10.1002/ijc.31312 ChanKKW SalujaR SantosKD LienK ShahK CramarossaG Neoadjuvant treatments for locally advanced, resectable esophageal cancer: a network meta-analysis Int J Cancer 2018 143 430 37 10.1002/ijc.31312 Open DOISearch in Google Scholar

7. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8: 545–53. doi: 10.1016/S1470-2045(07)70172-9 MarietteC PiessenG TribouletJP Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities Lancet Oncol 2007 8 545 53 10.1016/S1470-2045(07)70172-9 Open DOISearch in Google Scholar

8. Beaton L, Bandula S, Gaze MN, Sharma RA. How rapid advances in imaging are defining the future of precision radiation oncology. Br J Cancer 2019; 120: 779–90. doi: 10.1038/s41416-019-0412-y BeatonL BandulaS GazeMN SharmaRA How rapid advances in imaging are defining the future of precision radiation oncology Br J Cancer 2019 120 779 90 10.1038/s41416-019-0412-y Open DOISearch in Google Scholar

9. Sillah K, Williams LR, Laasch HU, Saleem A, Watkins G, Pritchard SA, et al. Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning. World J Gastrointest Oncol 2010; 2: 197–204. doi: 10.4251/wjgo.v2.i4.197 SillahK WilliamsLR LaaschHU SaleemA WatkinsG PritchardSA Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning World J Gastrointest Oncol 2010 2 197 204 10.4251/wjgo.v2.i4.197 Open DOISearch in Google Scholar

10. Decazes P, Hinault P, Veresezan O, Thureau S, Gouel P, Vera P. Trimodality PET/CT/MRI and radiotherapy: a mini-review. Front Oncol 2021; 10: 1–9. doi: 10.3389/fonc.2020.614008 DecazesP HinaultP VeresezanO ThureauS GouelP VeraP Trimodality PET/CT/MRI and radiotherapy: a mini-review Front Oncol 2021 10 1 9 10.3389/fonc.2020.614008 Open DOISearch in Google Scholar

11. Lambrecht M, Haustermans K. Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors. Radiother Oncol 2010; 96: 339–46. doi: 10.1016/j.radonc.2010.07.019 LambrechtM HaustermansK Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors Radiother Oncol 2010 96 339 46 10.1016/j.radonc.2010.07.019 Open DOISearch in Google Scholar

12. Lu J, Sun XD, Yang X, Ang XY, Qin Q, Zhu HC, et al. Impact of PET/CT on radiation treatment in patients with esophageal cancer: a systematic review. Crit Rev Oncol Hematol 2016; 107: 128–37. doi: 10.1016/j.critrevonc.2016.08.015 LuJ SunXD YangX AngXY QinQ ZhuHC Impact of PET/CT on radiation treatment in patients with esophageal cancer: a systematic review Crit Rev Oncol Hematol 2016 107 128 37 10.1016/j.critrevonc.2016.08.015 Open DOISearch in Google Scholar

13. Jiang C, Chen Y, Zhu Y, Xu Y. Systematic review and meta-analysis of the accuracy of 18F-FDG PET/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma. J Thorac Dis 2018; 10: 6066–76. doi: 10.21037/jtd.2018.10.57 JiangC ChenY ZhuY XuY Systematic review and meta-analysis of the accuracy of 18F-FDG PET/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma J Thorac Dis 2018 10 6066 76 10.21037/jtd.2018.10.57 Open DOISearch in Google Scholar

14. Garcia B, Goodman KA, Cambridge L, Dunphy M, Wu AJ. Distribution of FDG-avid nodes in esophageal cancer: Implications for radiotherapy target delineation. Radiat Oncol 2016; 11: 1–8. doi: 10.1186/s13014-016-0731-6 GarciaB GoodmanKA CambridgeL DunphyM WuAJ Distribution of FDG-avid nodes in esophageal cancer: Implications for radiotherapy target delineation Radiat Oncol 2016 11 1 8 10.1186/s13014-016-0731-6 Open DOISearch in Google Scholar

15. Machiels M, Wouterse SJ, Geijsen ED, van Os RM, Bennink RJ, van Laarhoven HW, et al. Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy. J Med Imaging Radiat Oncol 2016; 60: 520–27. doi: 10.1111/1754-9485.12474 MachielsM WouterseSJ GeijsenED van OsRM BenninkRJ van LaarhovenHW Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy J Med Imaging Radiat Oncol 2016 60 520 27 10.1111/1754-9485.12474 Open DOISearch in Google Scholar

16. Münch S, Marr L, Feuerecker B, Dapper H, Braren R, Combs SE, et al. Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients. Strahlentherapie Onkol 2020; 196: 787–94. doi: 10.1007/s00066-020-01630-y MünchS MarrL FeuereckerB DapperH BrarenR CombsSE Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients Strahlentherapie Onkol 2020 196 787 94 10.1007/s00066-020-01630-y Open DOISearch in Google Scholar

17. Thomas L, Lapa C, Bundschuh RA, Polat B, Sonke JJ, Guckenberger M. Tumour delineation in oesophageal cancer – a prospective study of delineation in PET and CT with and without endoscopically placed clip markers. Radiother Oncol 2015; 116: 269–75. doi: 10.1016/j.radonc.2015.07.007 ThomasL LapaC BundschuhRA PolatB SonkeJJ GuckenbergerM Tumour delineation in oesophageal cancer – a prospective study of delineation in PET and CT with and without endoscopically placed clip markers Radiother Oncol 2015 116 269 75 10.1016/j.radonc.2015.07.007 Open DOISearch in Google Scholar

18. Mamede M, El Fakhri G, Abreu-E-Lima P, Andler W, Nosé V, Gerbaudo VH. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med 2007; 21: 553–62. doi: 10.1007/s12149-007-0040-0 MamedeM El FakhriG Abreu-E-LimaP AndlerW NoséV GerbaudoVH Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation Ann Nucl Med 2007 21 553 62 10.1007/s12149-007-0040-0 Open DOISearch in Google Scholar

19. Han D, Yu J, Yu Y, Zhang G, Zhong X, Lu J, et al. Comparison of 18F-Fluorothymidine and 18F-Fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus. Int J Radiat Oncol Biol Phys 2010; 76: 1235–41. doi: 10.1016/j.ijrobp.2009.07.1681 HanD YuJ YuY ZhangG ZhongX LuJ Comparison of 18F-Fluorothymidine and 18F-Fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus Int J Radiat Oncol Biol Phys 2010 76 1235 41 10.1016/j.ijrobp.2009.07.1681 Open DOISearch in Google Scholar

20. Zhong X, Yu J, Zhang B, Mu D, Zhang W, Li D, et al. Using 18F-Fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009; 73: 136–41. doi: 10.1016/j.ijrobp.2008.04.015 ZhongX YuJ ZhangB MuD ZhangW LiD Using 18F-Fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 2009 73 136 41 10.1016/j.ijrobp.2008.04.015 Open DOISearch in Google Scholar

21. Nowee ME, Voncken FEM, Kotte ANTJ, Goense L, van Rossum PSN, van Lier ALHMW, et al. Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: a nationwide study. Clin Transl Radiat Oncol 2018; 14: 33–9. doi: 10.1016/j.ctro.2018.10.003 NoweeME VonckenFEM KotteANTJ GoenseL van RossumPSN van LierALHMW Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: a nationwide study Clin Transl Radiat Oncol 2018 14 33 9 10.1016/j.ctro.2018.10.003 Open DOISearch in Google Scholar

22. Toya R, Matsuyama T, Saito T, Imuta M, Shiraishi S, Fukugawa Y, et al. Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: reducing interobserver variation. J Radiat Res 2019; 60: 348–52. doi: 10.1093/jrr/rrz004 ToyaR MatsuyamaT SaitoT ImutaM ShiraishiS FukugawaY Impact of hybrid FDG-PET/CT on gross tumor volume definition of cervical esophageal cancer: reducing interobserver variation J Radiat Res 2019 60 348 52 10.1093/jrr/rrz004 Open DOISearch in Google Scholar

23. Vesprini D, Ung Y, Dinniwell R, Breen S, Cheung F, Grabarz D, et al. Improving observer variability in target delineation for gastro-oesophageal cancer – the role of 18Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography. Clin Oncol 2008; 20: 631–38. doi: 10.1016/j.clon.2008.06.004 VespriniD UngY DinniwellR BreenS CheungF GrabarzD Improving observer variability in target delineation for gastro-oesophageal cancer – the role of 18Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography Clin Oncol 2008 20 631 38 10.1016/j.clon.2008.06.004 Open DOISearch in Google Scholar

24. Schreurs LM, Busz DM, Paardekooper GM, Beukema JC, Jager PL, Van der Jagt EJ, et al. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability. Dis Esophagus 2010; 23: 493–501. doi: 10.1111/j.1442-2050.2009.01044.x SchreursLM BuszDM PaardekooperGM BeukemaJC JagerPL Van der JagtEJ Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability Dis Esophagus 2010 23 493 501 10.1111/j.1442-2050.2009.01044.x Open DOISearch in Google Scholar

25. Li F, Li Y, Wang X, Zhang Y, Liu X, Liu S, et al. Inter-observer and Intra-observer variability in gross tumor volume delineation of primary esophageal carcinomas based on different combinations of diagnostic multimodal images. Front Oncol 2022; 12: 1–10. doi: 10.3389/fonc.2022.817413 LiF LiY WangX ZhangY LiuX LiuS Inter-observer and Intra-observer variability in gross tumor volume delineation of primary esophageal carcinomas based on different combinations of diagnostic multimodal images Front Oncol 2022 12 1 10 10.3389/fonc.2022.817413 Open DOISearch in Google Scholar

26. Shi J, Li J, Li F, Zhang Y, Guo Y, Wang W, et al. Comparison of the gross target volumes based on diagnostic PET/CT for primary esophageal cancer. Front Oncol 2021; 11: 1–10. doi: 10.3389/fonc.2021.550100 ShiJ LiJ LiF ZhangY GuoY WangW Comparison of the gross target volumes based on diagnostic PET/CT for primary esophageal cancer Front Oncol 2021 11 1 10 10.3389/fonc.2021.550100 Open DOISearch in Google Scholar

27. van Rossum PSN, Van Lier ALHMW, Lips IM, Meijer GJ, Reerink O, van Vulpen M, et al. Imaging of oesophageal cancer with FDG-PET/CT and MRI. Clin Radiol 2015; 70: 81–95. doi: 10.1016/j.crad.2014.07.017 van RossumPSN Van LierALHMW LipsIM MeijerGJ ReerinkO van VulpenM Imaging of oesophageal cancer with FDG-PET/CT and MRI Clin Radiol 2015 70 81 95 10.1016/j.crad.2014.07.017 Open DOISearch in Google Scholar

28. Hou DL, Shi GF, Gao XS, Asaumi J, Li XY, Liu H, et al. Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma. Radiat Oncol 2013; 8: 169. doi: 10.1186/1748-717X-8-169 HouDL ShiGF GaoXS AsaumiJ LiXY LiuH Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma Radiat Oncol 2013 8 169 10.1186/1748-717X-8-169 Open DOISearch in Google Scholar

29. Vollenbrock SE, Nowee ME, Voncken FEM, Kotte ANTJ, Goense L, van Rossum PSN, et al. Gross tumor delineation in esophageal cancer on MRI compared with 18F-FDG-PET/CT. Adv Radiat Oncol 2019; 4: 596–604. doi: 10.1016/j.adro.2019.04.004 VollenbrockSE NoweeME VonckenFEM KotteANTJ GoenseL van RossumPSN Gross tumor delineation in esophageal cancer on MRI compared with 18F-FDG-PET/CT Adv Radiat Oncol 2019 4 596 604 10.1016/j.adro.2019.04.004 Open DOISearch in Google Scholar

30. Kouwenhoven E, Giezen M, Struikmans H. Measuring the similarity of target volume delineations independent of the number of observers. Phys Med Biol 2009; 54: 2863–73. doi: 10.1088/0031-9155/54/9/018 KouwenhovenE GiezenM StruikmansH Measuring the similarity of target volume delineations independent of the number of observers Phys Med Biol 2009 54 2863 73 10.1088/0031-9155/54/9/018 Open DOISearch in Google Scholar

31. Warfield SK, Zou KH, Wells WM. Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation. IEEE Trans Med Imaging 2004; 23: 903–21. doi: 10.1109/TMI.2004.828354 WarfieldSK ZouKH WellsWM Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation IEEE Trans Med Imaging 2004 23 903 21 10.1109/TMI.2004.828354 Open DOISearch in Google Scholar

32. Petrič P, Hudej R, Rogelj P, Blas M, Tanderup K, Fidarova E, et al. Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study. Radiother Oncol 2013; 107: 6–12. doi: 10.1016/j.radonc.2013.01.014 PetričP HudejR RogeljP BlasM TanderupK FidarovaE Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study Radiother Oncol 2013 107 6 12 10.1016/j.radonc.2013.01.014 Open DOISearch in Google Scholar

33. Rogelj P, Hudej R, Petric P. Distance deviation measure of contouring variability. Radiol Oncol 2013; 47: 86–96. doi: 10.2478/raon-2013-0005 RogeljP HudejR PetricP Distance deviation measure of contouring variability Radiol Oncol 2013 47 86 96 10.2478/raon-2013-0005 Open DOISearch in Google Scholar

34. Šegedin B. [Objective evaluation of the impact of learning on differences in the contouring of target volumes in radiotherapy]. [Slovenian]. Doctoral thesis. Ljubljana: University of Ljubljana. Medical Faculty; 2016. ŠegedinB. [Objective evaluation of the impact of learning on differences in the contouring of target volumes in radiotherapy]. [Slovenian]. Doctoral thesis. Ljubljana University of Ljubljana Medical Faculty; 2016 Search in Google Scholar

35. Machiels M, Jin P, van Hooft JE, Gurney-Champion OJ, Jelvehgaran P, Geijsen ED, et al. Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers. Acta Oncol 2019; 58: 943–50. doi: 10.1080/0284186X.2019.1588991 MachielsM JinP van HooftJE Gurney-ChampionOJ JelvehgaranP GeijsenED Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers Acta Oncol 2019 58 943 50 10.1080/0284186X.2019.1588991 Open DOISearch in Google Scholar

36. Wu YW, Tseng PH, Lee YC, Wang SY, Chiu HM, Tu CH, et al. Association of esophageal inflammation, obesity and gastroesophageal reflux disease: From FDG PET/CT perspective. PLoS One 2014; 9: e92001. doi: 10.1371/journal.pone.0092001 WuYW TsengPH LeeYC WangSY ChiuHM TuCH Association of esophageal inflammation, obesity and gastroesophageal reflux disease: From FDG PET/CT perspective PLoS One 2014 9 e92001 10.1371/journal.pone.0092001 Open DOISearch in Google Scholar